NASDAQ:SMMT   Summit Therapeutics Inc.
Reversal on the 4 hour, from a huge drop in Dec due to poor results for their trials when they combined data. They said 2022 end of 1st quarter they will release an update. They stopped the offering to investors and will give an update later.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。